Biodegradable and Injectable Paclitaxel-Loaded Poly(ester amide)s Microspheres: Fabrication and Characterization

被引:56
作者
Guo, Kai
Chu, C. C. [1 ]
机构
[1] Cornell Univ, Fiber & Polymer Sci Program, Dept Fiber Sci & Apparel Design, Ithaca, NY 14853 USA
关键词
polyesteramide; biodegradable microspheres; solvent evaporation; enzymatic degradation; DRUG-DELIVERY SYSTEMS; CONTROLLED-RELEASE; IN-VITRO; CONTAINING LIPOSOMES; POLYMERIC MICELLES; TAXOL; FORMULATION; COPOLYMERS; HYDROGELS; VIVO;
D O I
10.1002/jbm.b.31239
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Novel biodegradable submicron microspheres of amino acid based poly(ester amide)s (PEAs) were fabricated by an oil-in-water (O/W) emulsion/solvent evaporation technique and their morphology and drug loading efficiency were examined. PEAs microspheres of mean diameter <1 mu m with very narrow size distribution were obtained at a fair yield about 80%. The effects of PEA polymer concentration, polyvinyl alcohol emulsifier concentration, and the homogenizer speed on the size and morphology of final PEA microspheres were examined by analyzing their SEM images. It is found that a low PEA concentration, a high PVA concentration, and a high homogenizer speed are the optimal conditions for obtaining smaller microspheres. The biodegradation behaviors of these PEA microspheres at 37 degrees C were investigated as a function of enzyme (alpha-chymotrypsin) concentration and incubation time. The data showed similar surface erosion degradation mechanism as PEA polymers reported previously. Paclitaxel loaded PEA microspheres with high encapsulation efficiency were obtained without significantly affecting their size and surface morphology. The high drug loading efficiency close to 100% suggested that PEA microspheres may have the potential for the injection administration of highly hydrophobic anticancer drugs. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 89B: 491-500, 2009
引用
收藏
页码:491 / 500
页数:10
相关论文
共 49 条
[1]   Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[2]  
BARROWS TH, 1983, T SOC BIOMATER, V6, P109
[3]   Synthesis, physico-chemical and biological characterization of a paclitaxel macromolecular prodrug [J].
Cavallaro, G ;
Licciardi, M ;
Caliceti, P ;
Salmaso, S ;
Giammona, G .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (01) :151-159
[4]   Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles [J].
Cho, YW ;
Lee, J ;
Lee, SC ;
Huh, KM ;
Park, K .
JOURNAL OF CONTROLLED RELEASE, 2004, 97 (02) :249-257
[5]   Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats [J].
Choi, JS ;
Jo, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 280 (1-2) :221-227
[6]  
Chu C. C., 2003, U.S. Patents, Patent No. [6503538, 6,503,538]
[7]   Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development [J].
Cleland, JL ;
Johnson, OL ;
Putney, S ;
Jones, AJS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :71-84
[8]   Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes [J].
Crosasso, P ;
Ceruti, M ;
Brusa, P ;
Arpicco, S ;
Dosio, F ;
Cattel, L .
JOURNAL OF CONTROLLED RELEASE, 2000, 63 (1-2) :19-30
[9]  
Das GS, 2001, J BIOMED MATER RES, V55, P96, DOI 10.1002/1097-4636(200104)55:1<96::AID-JBM130>3.0.CO
[10]  
2-3